Arginine Replacement Therapy in COVID-19

PHASE2RecruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
COVID-19
Interventions
DRUG

Arginine Hydrochloride

Arginine will be infused based on the manufacturer's instructions (R-Gene 10, Pfizer), over 30 minutes. However, rates may be slowed to over 60 minutes for patients experiencing symptoms of flushing, nausea, vomiting, or headache at the research team's discretion. Pediatric doses will be drawn up by the pharmacy.

Trial Locations (1)

30322

RECRUITING

Children's Healthcare of Atlanta (CHOA), Arthur M. Blank, Atlanta

All Listed Sponsors
lead

Emory University

OTHER